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Abstract 
HNK-1 (human natural killer-1) carbohydrate epitope (HSO3-3GlcAβ1-3Galβ1-4GlcNAc-) 
recognized by a HNK-1 monoclonal antibody is highly expressed in the nervous system and 
biosynthesized by a glucuronyltransferase (GlcAT-P or GlcAT-S), and sulfotransferase 
(HNK-1ST). A similar oligosaccharide (HSO3-3GlcAβ1-3Galβ1-3Galβ1-4Xyl) also recognized 
by the HNK-1 antibody had been found in a glycosaminoglycan (GAG)-protein linkage region 
of α-thrombomodulin (TM) from human urine. However, which sulfotransferase is involved in 
sulfation of the terminal GlcA in the GAG-protein linkage region remains unclear. In this study, 
using CHO-K1 cells in which neither GlcAT-P nor GlcAT-S is endogenously expressed, we 
found that HNK-1ST has the ability to produce HNK-1 immnoreactivity on α-TM. We also 
demonstrated that HNK-1ST caused the suppression of chondroitin sulfate (CS) synthesis on 
TM and a reduction of its anti-coagulant activity. Moreover, using an in vitro enzyme assay 
system, the HNK-1-positive TM was found not to be utilized as a substrate for CS-polymerizing 
enzymes (chondroitin synthase (ChSy) and chondroitin polymerizing factor (ChPF)). These 
results suggest that HNK-1ST is involved in 3-O-sulfation of the terminal GlcA of the linkage 
tetrasaccharide which acts as an inhibitory signal for the initiation of CS biosynthesis on TM. 
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Proteoglycans (PGs) ubiquitously expressed on the cell surface and in the extracellular matrix, 
are physiologically essential macromolecules modified by glycosaminoglycan (GAG) 
sidechains including chondroitin sulfate (CS) and heparan sulfate (HS). GAGs have a linear 
polysaccharide structure comprised of repeating disaccharide units, [(-4GlcAβ1-3GalNAcβ1-)n] 
for CS and [(-4GlcAβ1-4GlcNAcα1-)n] for HS [1]. The polymerization of GAGs is triggered by 
the first transfer reaction of GalNAc or GlcNAc to the non-reducing terminus of the 
GAG-protein linkage tetrasaccharide, GlcAβ1-3Galβ1-3Galβ1-4Xyl-O-Ser [1]. This unique 
tetrasaccharide is generated by xylosyltransferase (XylT), galactosyltransferase (GalT)-I, 
GalT-II, and glucuronyltransferase I (GlcAT-I) [1-6]. GAGs attached to a protein core are 
further processed by modifications such as sulfation and epimerization to various degrees 
dependent on tissue type or developmental stage, generating fully functional PGs [7, 8].  
     Thrombomodulin (TM), a cell surface PG, is a critical mediator of endothelial 
anti-coagulant defenses occurring as both a CS-PG (β-TM) and a protein (α-TM) unsubstituted 
by CS, hence its description as a “part-time” PG [9]. Studies on the anti-coagulant effects of TM 
demonstrated that it has cofactor activity for thrombin-dependent activation of protein C, direct 
inhibition of fibrinogen cleavage by thrombin, and indirect enhancement of the association of 
antithrombin III with thrombin [10]. We previously demonstrated that a recombinant human 
α-TM expressed in CHO-K1 cells bore a truncated un-modified tetrasaccharide linkage 
structure [11]. Comparative studies on the anti-coagulant effects of α-TM and β-TM revealed 
that the CS chain of TM plays an important role in regulating the anti-coagulative functions [12]. 
Thus, it is important to investigate a possible biosynthetic mechanism for part-time PGs. 
     Human natural killer-1 (HNK-1), a neural carbohydrate epitope abundantly expressed 
during the brain development, is required for the acquisition of higher-order brain functions 
including synaptic plasticity [13-15]. A structural feature of this epitope is the terminal sulfated 
glucuronic acid. Therefore, glucuronyltransferase (GlcAT-P or GlcAT-S) and HNK-1 
sulfotransferase (HNK-1ST) are key enzymes for HNK-1 biosynthesis. We demonstrated that 
GlcAT-P (also GlcAT-S) and HNK-1ST specifically interact and form an enzyme complex 
effective of HNK-1 biosynthesis [16]. Intriguingly, we also found that HNK-1ST interacts with 
GlcAT-I, implying a physiological role for this association [16]. In addition, 3-O-sulfation of the 
terminal GlcA of the linkage tetrasaccharide was identified in α-TM isolated from human urine 
and this structure was recognized by a HNK-1 monoclonal antibody (mAb) [17]. These findings, 
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led us to the hypothesis that HNK-1ST is the sulfotransferase responsible for the terminal 
3-O-sulfation of the linkage region. In this regard, recent studies identified various 
modifications of the linkage tetrasaccharide and revealed their effects on GAG biosynthesis, 
providing important clues as to the biosynthetic mechanism of GAG. For instance, 
2-O-phosphorylation of xylose positively affects GlcAT-I activity, facilitating the linkage 
tetrasaccharide synthesis [18]. FAM20B was identified as a kinase responsible for the 
2-O-phosphorylation of xylose and shown to modulate the number of GAG chains [19]. 
Moreover, during the preparation of this manuscript, Hashiguchi et al. demonstrated the 
sulfotransferase activity of HNK-1ST toward the GlcA of the GAG-linkage region with an in 
vitro enzymatic assay system using a peptide containing the tetrasaccharide [20]. However, the 
biological significance of the sulfate group on GlcA remains unclear. 
     In this study, we explored the involvement of HNK-1ST in the modification of the 
protein-linkage region and regulation of GAG assembly. Using a soluble form of recombinant 
TM, we found that HNK-1ST actually sulfated the linkage region and induced 
immunoreactivity with a HNK-1 mAb. HNK-1ST had the ability to suppress the GAG-bearing 
form of TM (β-TM) and anti-coagulant activity of TM. Moreover, CS chain polymerization 
reaction was not observed on the HNK-1-positive TM, suggesting the terminal 3-O-sulfation of 
the linkage tetrasaccharide to act as an inhibitory signal for the initiation of GAG biosynthesis. 
 
4 
2. Materials and methods 
 
2.1. Materials 
HNK-1 mAb was purchased from the American Type Culture Collection. The mouse anti-EGFP 
and anti-myc mAbs were from Clontech and Millipore, respectively. The HRP-conjugated 
anti-mouse IgG and anti-mouse IgM were obtained from Invitrogen. The nickel-nitrilotriacetic 
acid (Ni-NTA)-conjugated agarose was from Qiagen. Chondroitinase ABC and peptide 
N-glycosidase F were purchased from Seikagaku Corp., Tokyo, Japan and Roche Applied 
Science, respectively. UDP-[3H]GalNAc (10 Ci/mmol) was from NEN Life Science Products. 
Unlabeled UDP-GlcA and UDP-GalNAc were obtained from Sigma (St Louis, MO, USA). 
 
2.2. cDNA construction 
The cDNA fragment encoding TM was amplified from a human leukocyte cDNA library 
(Clontech) as a template with the primers CGGGATCCGGTAACATGCTTGGGGTCCTG 
containing a BamHI site and CCAAGCTTCGAATGCACGAGCCCCACGG containing a 
HindIII site. The PCR fragments were subcloned into pcDNA3.1(–) myc/His (Invitrogen) 
(sTM-myc). The expression plasmid for EGFP-tagged rat HNK-1ST (ST-EGFP) was described 
previously [16]. The plasmid encoding the R189A mutant of HNK-1ST (R189A-EGFP) was 
constructed from ST-EGFP, using a QuikChange Lightning Site-Directed Mutagenesis Kit 




2.3. Cell culture and transfection 
CHO-K1 cells were maintained in α-minimum essential medium with 10% fetal bovine serum 
(FBS) in 5% CO2 at 37°C. The cells were grown overnight and transfected with cDNA using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. The culture 
medium was replaced with serum-free OPTI-MEM I (Invitrogen) 5 h after transfection, and the 
cells were cultured another 2 days.  
 
2.4. Western blot analysis 
Proteins solubilized in Laemmli sample buffer were separated by SDS-PAGE using 7% 
polyacrylamide gels and then transferred to nitrocellulose membranes. After blocking with 5% 
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nonfat dry milk in phosphate-buffered saline containing 0.05% Tween 20, the membranes were 
incubated with primary antibodies, followed by HRP-conjugated secondary antibodies. Protein 
bands were detected with Super Signal West Pico chemiluminescence reagent (Thermo 
Scientific) using a LAS-3000 Luminoimage Analyzer (FUJIFILM). 
 
2.5. Purification of recombinant sTM-myc 
CHO-K1 cells plated on 175 cm2 tissue culture flasks were transfected with sTM-myc with or 
without ST-EGFP using the Lipofectamine 2000 transfection reagent. After 5 h, the culture 
medium was replaced with serum-free ASF104 medium (Ajinomoto), and the cells were 
cultured for another 3 days. Then, the culture medium containing secreted proteins was applied 
to a HisTrap TM HP column (GE Healthcare). Unbound proteins were washed out with more 
than 10 column volumes of phosphate buffer (pH 7.4) containing 300 mM NaCl and 20 mM 
imidazole. Bound proteins were eluted with phosphate buffer (pH 7.4) containing 300 mM NaCl 
and 500 mM imidazole. Then, the eluted materials were dialyzed with 20 mM Tris-HCl buffer 
(pH 7.4) containing 100 mM NaCl. 
 
2.6. Measurement of the anti-coagulant activity of TM  
The anti-coagulant activity of TM was determined by its ability to inhibit thrombin clotting 
activity with fibrinogen (Sigma) as described [10, 21]. Fibrinogen clotting was monitored 
visually. Thrombin (18 nM, Sigma) was incubated for 1 min at 37°C with TM, chondroitinase 
ABC-treated TM, or TM+HNK-1ST at various molar ratios. Fibrinogen (2.0 mg/ml, final 
concentration) was then added and the clotting time was determined. The assays were 
performed in 0.02 M Tris-HCl buffer (pH 7.5) containing 0.1 M NaCl and 1 mg/ml bovine 
serum albumin. 
 
2.7. CS polymerization assay 
The ChSy-1 and ChPF expression plasmids (3.0 µg each) were co-transfected into COS-1 cells 
on 100-mm plates using FuGENETM 6 (Roche Molecular Biochemicals, Tokyo, Japan) as 
described previously [22]. Two days after transfection, 1 ml of the culture medium was 
collected and incubated with 10 µl of IgG-Sepharose (Amersham Pharmacia Biotech) for 1 h at 
4°C. The beads recovered by centrifugation were washed with and resuspended in the assay 
buffer, and then tested for GalNAc transferase activity, as described [23]. Polymerization 
reactions using TM or TM+HNK-1ST as acceptors were co-incubated in reaction mixtures 
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containing the following constituents in a total volume of 50 µl: 0.1 nmol TM or TM+HNK-1ST, 
0.25 mM UDP-[3H]GalNAc (5 × 105 dpm), 0.25 mM UDP-GlcA, 100 mM MES buffer, pH 6.5, 
10 mM MnCl2, and 10 µl of the resuspended beads. The mixtures were incubated at 37°C 
overnight. Products of the polymerization reactions were isolated by gel filtration using a 
syringe column packed with Sephadex G-25 (superfine) [24]. The flow-through fractions were 




3. Results and discussion 
 
3.1. HNK-1ST suppresses CS modification of TM 
To investigate the involvement of HNK-1ST in the modification of the protein-linkage region in 
TM, a soluble form of myc/His-tagged TM (sTM-myc) was transiently expressed in CHO-K1 
cells with or without EGFP-tagged HNK-1ST (ST-EGFP). Although TM is an integral 
membrane protein, sTM-myc is designed to be secreted into the culture medium by truncating 
the transmembrane domain. The secreted sTM-myc was pulled down from the culture medium 
with nickel-nitrilotriacetic acid (Ni-NTA)-conjugated agarose beads, and subjected to Western 
blotting. When sTM-myc was expressed alone, both TM glycoforms, the CS chain-bearing form 
(β-ΤΜ) and non-bearing form (α-TM), were detected by anti-myc antibody (Fig. 1A). After 
digestion with chondroitinase ABC (CSase ABC), the upper smear (β-ΤΜ) disappeared and 
converged with the 100 kDa band (α-TM) (Fig.1B), indicating that sΤΜ-myc was actually 
modified by the CS chain in CHO-K1 cells. Interestingly, however, with the co-expression of 
sTM-myc and ST-EGFP, β-TM production was markedly reduced, and conversely, the amount 
of α-ΤΜ increased, indicating that most TM remains as a CS chain-lacking α-form in the 
presence of HNK-1ST (Fig. 1A). Moreover, HNK-1 immunoreactivity was detected on the 
α-form of sTM-myc co-expressed with ST-EGFP (Fig. 1A). Since neither GlcAT-P nor GlcAT-S 
is endogenously expressed in CHO-K1 cells, the HNK-1 epitope might be synthesized by 
GlcAT-I and HNK-1ST. To further characterize the HNK-1 epitope on sTM-myc, 
HNK-1-positive sTM-myc was treated with peptide N-glycosidase F (PNGase F) to remove the 
N-linked glycans. The molecular weight of sTM-myc was slightly decreased, but HNK-1 
immunoreactivity was unchanged after the PNGase F treatment (Fig. 1C), indicating that TM 
carries N-linked glycans but the HNK-1 epitope does not attach to it. Considering our previous 
finding that the linkage tetrasaccharide (GlcAβ1-3Galβ1-3Galβ1-4Xyl) is the only 
oligosaccharide detected on α-ΤΜ expressed in CHO-K1 cells and HNK-1ST transfers a sulfate 
group to the C-3 position of the non-reducing terminal GlcA, HNK-1ST appeared to be 
involved in the biosynthesis of the GAG-linkage-type HNK-1 epitope 
(HSO3-3GlcAβ1-3Galβ1-3Galβ1-4Xyl) found in human urine [17].  
 
3.2. The sulfotransferase activity of HNK-1ST is required for regulating the attachment of the 
CS chain 
Next, to determine the requirement of the enzymatic activity of HNK-1ST to arrest the initiation 
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of the CS chain, we generated an activity-depleted mutant of HNK-1ST, which harbors a 
mutation of Arg189 to Ala (R189A-EGFP). This mutant is reported to show almost no activity 
due to impaired binding to the donor substrate, 3’-phosphoadenosine 5’-phosphosulfate (PAPS) 
[25]. When co-expressed with R189A-EGFP, sTM-myc contained a comparable amount of the 
β-form to that expressed alone and did not exhibit HNK-1 immunoreactivity on its α-form (Fig. 
2). This result indicates that the regulatory function of HNK-1ST is achieved by the transfer of a 
sulfate group to the C-3 position of GlcA. Taken together, these results suggest that the sulfation 
of terminal GlcA in the GAG-linkage tetrasaccharide by HNK-1ST negatively regulates the CS 
chain on TM. 
 
3.3. HNK-1ST controls the anti-coagulant activity of TM by regulating the attachment of the CS 
chain 
TM is expressed on the endothelial cell surface, and plays a pivotal role in anti-coagulation, 
including the inhibition of the procoagulant activity of thrombin [10]. Since the anti-coagulant 
activity of TM is highly dependent on its CS chain [10, 12], we examined whether HNK-1ST is 
able to control the function of TM by regulating the attachment of the CS chain. To measure 
anti-coagulant activity, we purified the recombinant sTM-myc from the culture medium of 
CHO-K1 cells with or without ST-EGFP co-expression. The purity of the recombinant protein 
was confirmed by CBB staining and Western blotting (Fig. 3A, B). Consistent with the data 
shown in Fig. 1, co-expression of HNK-1ST resulted in a reduction in β-TM and the appearance 
of HNK-1-immunoreactivity (Fig. 3A, B). Then, a thrombin-dependent clotting assay was 
performed to evaluate the anti-coagulant activity of purified sTM-myc. sTM-myc (TM in Fig. 
3C), which was not co-expressed with ST-EGFP, caused a dose-dependent delay in the clotting 
time, while the removal of the CS chain by the pre-treatment with CSase ABC greatly abrogated 
the anti-coagulant activity of sTM-myc (TM(CSase) in Fig. 3C). Then, we employed the same 
assay using sTM-myc co-expressed with ST-EGFP (TM+HNK-1ST). TM+HNK-1ST showed 
almost no inhibition of thrombin-induced clotting, similar to the CSase-treated sTM-myc (Fig. 
3C). These results suggest that TM is scarcely modified by the CS chain in the presence of 
HNK-1ST, leading to the loss of TM function. 
 
3.4. The terminal 3-O-sulfation of the linkage tetrasaccharide has an inhibitory function in the 
initiation of CS biosynthesis 
The initiation and elongation of CS chains are conducted by an enzyme complex of chondroitin 
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synthase (ChSy-1 to 3) and chondroitin polymerizing factor (ChPF) [22, 26]. Therefore, to 
demonstrate that the terminal sulfate group transferred by HNK-1ST to the linkage 
tetrasaccharide indeed acts as a stop signal that inhibits the addition of CS, we measured the 
chondroitin-polymerizating activity of ChSy/ChPF against sTM-myc described in Fig. 3. When 
sTM-myc expressed without ST-EGFP (TM in Table 1) was used as an acceptor substrate, 
significant polymerization by ChSy/ChPF (17.8 pmol/mg/h) was observed (Table 1). However, 
we could not detect any activity against sTM-myc co-expressed with ST-EGFP (TM+HNK-1ST 
in Table 1), indicating that the sulfated linkage region tetrasaccharide is not utilized as a 
substrate for CS-polymerizing enzymes.  
     In this report, we demonstrated that HNK-1ST synthesizes a HNK-1 antibody-reactive 
epitope on α-TM and suppresses the expression of β-TM in an activity-dependent manner. We 
also produced evidence that α-TM bearing this epitope is not utilized as a substrate for 
CS-polymerizing enzymes. We did not precisely determine the structure of the HNK-1-reactive 
epitope but the sulfate group transferred by HNK-1ST is presumably expressed on the terminal 
GlcA at the C-3 position of the GAG-linkage region. The reason for this is that HNK-1ST is 
known to transfer a sulfate group from PAPS to the C-3 position of the non-reducing terminal 
GlcA residue and the resultant epitope is recognized by HNK-1 antibody [27]. Furthermore, 
Hashiguchi et al. have directly demonstrated the sulfotransferase activity of HNK-1ST toward 
the GlcA of the GAG-linkage region with an in vitro enzymatic assay system using chemically 
synthesized substrates. These results suggest that HNK-1ST forms an enzyme complex with 
GlcAT-I and regulates the expression of the CS chain of TM to control anti-coagulation. 
      Since 3-O-sulfation suppressed the assembly of CS, this sulfate group might be used as 
an inhibitory signal to control the function of PGs through the modification of GAGs. At the 
initiation step of the polymerization of CS chains, the first GalNAc is transferred to the C-4 
position of the terminal GlcA of the linkage region tetrasaccharide [1]. Therefore, the 
3-O-sulfation by HNK-1ST does not directly compete with the transfer of the first GalNAc, and 
there might be an underlying mechanism by which the sulfate group inhibits the initial 
GalNAc-transfer, for example, steric hindrance. Although we have shown the effect of 
3-O-sulfation on the attachment of CS chains, its influence on HS synthesis is unclear. Since the 
first GlcNAc of HS chains is also transferred to the C-4 position of the terminal GlcA, it is 
possible that the 3-O-sulfate exerts a similar inhibitory effect on the assembly of HS. However, 
the linkage tetrasaccharide containing 3-O-sulfated GlcA on HS-bearing PGs is still to be 
identified. 
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     HNK-1ST is generally known as a sulfotransferase involved in the biosynthesis of a 
HNK-1 carbohydrate epitope mainly expressed on N-glycans in the nervous system. The 
expression of the HNK-1 carbohydrate is predominantly restricted to the nervous tissue due to 
limited distributions of GlcAT-P and GlcAT-S [28, 29]. HNK-1ST, however, is more ubiquitous 
than GlcAT-P or GlcAT-S [27, 30], supporting our idea that HNK-1ST contributes to the 
regulation of GAG attachment, a second role different from that in the biosynthesis of the 
HNK-1 epitope expressed on N-glycans. 
     The 3-O-sulfated tetrasaccharide structure has been found in α-TM purified from human 
urine and serum [17, 20]. In this study, we demonstrated that the sulfated structure is 
biosynthesized by HNK-1ST and is not utilized as a substrate for CS-polymerizing enzymes. 
These lines of evidence indicate the possibility that the CS-modulating function of HNK-1ST is 
employed to maintain the homeostasis of the blood circulation system in vivo. In CHO-K1 cells, 
however, a significant amount of α-TM bearing un-sulfated tetrasaccharide linkage structure 
was expressed even without HNK-1ST transfection (Fig. 1B, and [11]), indicating the presence 
of another regulatory mechanism of part-time PGs. Since the CS of TM plays a crucial role in 
its anti-coagulant activities, it is of great interest to clarify the overall sorting mechanism for 
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Figure 1. Effect of HNK-1ST on the expression of the HNK-1 epitope and CS chain on TM. 
(A) sTM-myc with or without HNK-1ST-EGFP (ST-EGFP) was transiently expressed in 
CHO-K1 cells. The secreted sTM-myc was pulled down from the culture medium and subjected 
to Western blotting using anti-myc and HNK-1 mAb (medium). The two glycoforms of TM (α- 
and β-TM) were detected (arrowheads). The CHO-K1 cell lysate was analyzed for 
HNK-1ST-EGFP expression (cell lysate). (B) sTM-myc was treated with chondroitinase ABC 
(CSase ABC) to remove the CS moiety and Western blotted with anti-myc mAb. (C) sTM-myc 
was prepared from HNK-1ST-EGFP co-expressing cells and treated with peptide N-glycosidase 
F (PNGase F), and subjected to Western blotting with anti-myc and HNK-1 mAb. 
 
Figure 2. Requirement of the sulfotransferase activity of HNK-1ST for the suppression of 
CS chain on TM. sTM-myc was co-transfected with ST-EGFP or the R189A mutant of 
HNK-1ST (R189A-EGFP). The secreted sTM-myc was pulled down and subjected to Western 
blotting using anti-myc and HNK-1 mAb (medium). The expression of HNK-1ST and 
HNK-1ST (R189A) was confirmed by Western blotting of the cell lysate (cell lysate). 
 
Figure 3. The effect of HNK-1ST on the anti-coagulant activity of TM. (A, B) sTM-myc 
expressed in the absence or presence of ST-EGFP was purified from the culture medium of 
CHO-K1 cells using a HisTrap column. The culture medium (charge), the pass-through fraction 
(pass), and the eluate were analyzed by CBB staining (A) and Western blotting using anti-myc 
(B). The HNK-1 expression was also assessed using the eluates (B). (C) The purified sTM-myc 
was subjected to the thrombin-dependent clotting assay. sTM-myc (TM, open circle), sTM-myc 
pre-treated with CSase ABC (TM(CSase), filled circle), and sTM-myc co-expressed with 
HNK-1ST (TM+HNK-1ST, triangle) were mixed with thrombin at different molar ratios as 





Table 1 Chondroitin polymerization on HNK-1-positive sTM-myc 
 
 
aND, not detected (<0.01 pmol/mg/h) 
 
Acceptor substrate Polymerization activity 
 pmol/mg/h 
TM (0.1 nmol) 17.8  
TM+HNK-1ST (0.1 nmol) NDa 
